Japan Tobacoo And Merck Part Company On Osteoporosis Candidate

I suppose the thought was that this candidate might one day reinvigorate the now-off-patent (and eroding via generics) market formerly held be Fosamax®. Not so, per Reuters, this morning:

. . . .Merck has ended a licensing agreement with Japan Tobacco to develop and market an experimental agent that stimulates bone growth for the treatment of osteoporosis. . . .

The two firms concluded the deal in 2008, giving Merck worldwide rights outside of Japan to develop and market the Japan Tobacco compound. . . .

Probably a wise decision.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s